Frequently, these new drugs show major clinical activity and significant improvement over currently available treatment early in their development. In cases where new drugs show so much promise, and particularly in cases where existing treatment options are limited, the traditional multi-phase, sequential drug development process may not be appropriate.
'traditional multi-phase, sequential drug development process may not be appropriate.' THIS IS KEY.
30 by April before data. 45 after data...
IMO. Fast track AND blockbuster designation..means they can get FDA approval and treat patients WHILE getting phase III done.
For PCYC, Those results prompted the FDA to grant breakthrough designation to promote collaboration, and inevitably to approve the drug after only a phase 2 clinical trial.
Same will happen for Mydicar in April....FDA will approve it after phase 2 results since it has breakthrough designation. Total market in US over $1 billion, Europe another $500 mil.
plus another 150k ?
this is scary before April news. Do they feel stock over 15 is good time to get out ?
February 45, 45.5 and February weekly 47 calls are active in total call volume of 5K contracts (1K puts) amid renewed takeover speculation. February weekly call option implied volatility is at 71, March is at 57, April is at 54; compared to its 26-week average of 56 according to Track Data. Active call volume suggests traders taking positions for large near term price movement.
2 early investors VCs sold...that is expected as they take money out and move it to other ventures.
Don't see any employees senior management selling..good sign.
stock is much cheaper than 3 weeks ago, and estimates have gone up for FY15. Earnings were very good, and next qtr is in line, which would be an easy beat.
time to giddyup.
almost at par with AAPL at current price.
Its 4.2 last year sales...for 2015 it is lower. We are in 2015 fiscal year now.
GPRO at 3.5 time sales is no longer inflated. That is why analyst said good entry point now.
dentdebt you are clearly a short, and are trying to come up with stupid reasons. Go away.
he was the ONLY reason stock too a 11% dump yesterday. Today no selling as much, and stock is flat. The other minor selling is being absorbed so that is a good sign.
dude, the CEO sold 5 MILLION shares at 22...so why did he do that.
Like I said, he sold 5 mil, but he got 14 mil.
Lot of people sold FB at 20...you also know that. He has lots of shares still.
He is an early investor (not GPRO employee), so maybe he needs the money to invest in some other ventures. Who knows.
If CEO and other top VPs dont' sell (employees), that is a good sign.
dude everyone sells at some time...go to indsider activitiy...people also sold at 22 IPO price...but stock went up to 90. And director who sold 5mil also got 14 mil shares on 17th.
We're feeling good. GoPro was one of the best-selling products this holiday, selling-in an average of 1,000 units per hour for the entire quarter," said GoPro Founder and CEO, Nicholas Woodman. "With this many new recruits to the GoPro movement, we're sure to see some incredible content in 2015."
They are lowballing q1 for sure...will beat nicely..international was up 70% YoY in Q4.
no one wants these cameras ? did you not see the earnings report...they sold millions of it and beat earnings by a hugh margin.
ITS THE lockup that has been driving stock down..now that its over shorts will cover and move on.